Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

149.22 

-0.96 -0.6%

as of Jun 22 '21

52 Week Range:

104.95 151.76


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment engages in the manufacture and wholesale distribution of luxury and sports eyewear. The Retail segment retails luxury and sports eyewear. The Lenses and Optical Instruments segment offers lenses and small equipment, including Varilux progressive lenses; Crizal antireflective, anti-smudge, and antistatic lenses; Transitions photochromic lenses; Eyezen lenses for users of computers, tablets, smartphones, and other connected devices; Xperio polarized sun lenses; and Nikon and Kodak corrective lens brands. It also provides lens edging and mounting instruments for opticians and prescription laboratories; optometry instruments for eye care professionals, schools, occupational medicine centers, military, and other institutions; and Transitions Signature Gen 8 photochromic lens, as well as develops solutions for online sales of optical products. The Equipment segment offers digital surfacing machines and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers. The Sunglasses and Readers segment provides non-prescription sunglasses and reading glasses under the Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear, and SolarShield brands; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel, and Disney; Bolon, Molsion, Qina, and Prosun brands; and Mujosh and Aojo brands. It has a network of 490 prescription laboratories and edging-mounting facilities. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 13.91
13.81
15.96
17.73
20.62
25.20
27.99
28.99
15.47
77.13
77.44
growth rate -0.7% 15.6% 11.1% 16.3% 22.2% 11.1% 3.6% -46.6% 398.6% 0.4%
Earnings BIT 639.43
697.58
837.55
865.00
997.00
1,215.00
1,274.00
1,673.00
1,512.00
2,037.00
694.00
growth rate 9.1% 20.1% 3.3% 15.3% 21.9% 4.9% 31.3% -9.6% 34.7% -65.9%
Avg.PE 22.78
22.47
27.62
27.62
8.23
8.23
29.11
30.11
25.82
42.11
47.15
growth rate -1.4% 22.9% 0.0% -70.2% 0.0% 253.7% 3.4% -14.3% 63.1% 12.0%
ROA 9.85
8.89
8.94
8.19
10.12
6.65
6.47
6.20
3.71
2.18
0.16
growth rate -9.8% 0.6% -8.4% 23.6% -34.3% -2.7% -4.2% -40.2% -41.2% -92.7%
ROE 16.16
15.99
16.71
15.98
21.43
14.25
13.12
11.96
5.53
3.19
0.25
growth rate -1.1% 4.5% -4.4% 34.1% -33.5% -7.9% -8.8% -53.8% -42.3% -92.2%
ROIC 13.91
13.01
13.36
12.60
15.54
10.18
9.71
9.29
5.02
2.89
0.39
growth rate -6.5% 2.7% -5.7% 23.3% -34.5% -4.6% -4.3% -46.0% -42.4% -86.5%
Cur. Ratio 1.38
1.26
1.51
1.49
1.07
1.15
0.94
1.18
1.00
1.91
2.22
growth rate -8.7% 19.8% -1.3% -28.2% 7.5% -18.3% 25.5% -15.3% 91.0% 16.2%
Quick Ratio 0.90
0.81
0.99
0.99
0.67
0.69
0.58
0.74
0.60
1.38
1.78
growth rate -10.0% 22.2% 0.0% -32.3% 3.0% -15.9% 27.6% -18.9% 130.0% 29.0%
Leverage 1.74
1.85
1.89
2.02
2.20
2.10
1.97
1.89
1.41
1.51
1.62
growth rate 6.3% 2.2% 6.9% 8.9% -4.6% -6.2% -4.1% -25.4% 7.1% 7.3%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 838.30
1,021.61
1,240.00
1,292.00
1,421.00
1,550.00
1,724.00
1,066.00
2,680.00
2,774.00
2,508.00
growth rate 21.9% 21.4% 4.2% 10.0% 9.1% 11.2% -38.2% 151.4% 3.5% -9.6%
Acct.Payable 489.00
502.00
564.00
624.00
697.00
907.00
1,745.00
1,770.00
1,864.00
growth rate 2.7% 12.4% 10.6% 11.7% 30.1% 92.4% 1.4% 5.3%
Cur.Assets 2,041.66
2,428.66
2,826.00
3,031.00
3,162.00
3,272.00
3,509.00
3,175.00
7,008.00
10,750.00
13,720.00
growth rate 19.0% 16.4% 7.3% 4.3% 3.5% 7.2% -9.5% 120.7% 53.4% 27.6%
Total Assets 5,213.00
6,158.20
6,907.00
7,577.00
10,789.00
11,971.00
13,163.00
10,064.00
48,398.00
52,583.00
52,318.00
growth rate 18.1% 12.2% 9.7% 42.4% 11.0% 10.0% -23.5% 380.9% 8.7% -0.5%
Cash 371.10
390.30
661.00
786.00
626.00
466.00
517.00
1,159.00
1,829.00
4,836.00
8,683.00
growth rate 5.2% 69.4% 18.9% -20.4% -25.6% 10.9% 124.2% 57.8% 164.4% 79.6%
Inventory 645.45
753.42
830.00
869.00
1,002.00
1,099.00
1,125.00
832.00
2,034.00
2,166.00
1,930.00
growth rate 16.7% 10.2% 4.7% 15.3% 9.7% 2.4% -26.0% 144.5% 6.5% -10.9%
Cur.Liabilities 1,478.09
1,926.67
1,874.00
2,038.00
2,950.00
2,853.00
3,718.00
2,093.00
7,474.00
5,617.00
6,171.00
growth rate 30.4% -2.7% 8.8% 44.8% -3.3% 30.3% -43.7% 257.1% -24.9% 9.9%
Liabilities 2,168.90
2,700.40
2,993.00
3,536.00
5,529.00
5,879.00
6,109.00
4,250.00
14,995.00
17,251.00
19,520.00
growth rate 24.5% 10.8% 18.1% 56.4% 6.3% 3.9% -30.4% 252.8% 15.1% 13.2%
LT Debt 285.60
309.20
522.00
603.00
1,515.00
1,901.00
1,361.00
1,648.00
2,564.00
6,864.00
9,324.00
growth rate 8.3% 68.8% 15.5% 151.2% 25.5% -28.4% 21.1% 55.6% 167.7% 35.8%
Equity 3,044.20
3,457.80
3,914.00
3,756.00
4,915.00
5,707.00
6,688.00
5,808.00
32,899.00
34,796.00
32,268.00
growth rate 13.6% 13.2% -4.0% 30.9% 16.1% 17.2% -13.2% 466.4% 5.8% -7.3%
Common Shares 213.00
210.00
211.00
213.00
215.00
217.00
219.00
221.00
266.00
441.00
439.00
growth rate -1.4% 0.5% 1.0% 0.9% 0.9% 0.9% 0.9% 20.4% 65.8% -0.5%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 124.20
-14.40
241.00
297.00
232.00
327.00
294.00
664.00
710.00
903.00
650.00
growth rate -100.0% 100.0% 23.2% -21.9% 41.0% -10.1% 125.9% 6.9% 27.2% -28.0%
Cash Dividends 146.50
171.50
177.00
186.00
198.00
216.00
79.00
440.00
484.00
887.00
503.00
growth rate 17.1% 3.2% 5.1% 6.5% 9.1% -63.4% 457.0% 10.0% 83.3% -43.3%
Cash From OA 619.50
667.80
840.00
843.00
1,032.00
1,194.00
1,194.00
1,603.00
2,359.00
3,299.00
2,953.00
growth rate 7.8% 25.8% 0.4% 22.4% 15.7% 0.0% 34.3% 47.2% 39.9% -10.5%
FCF per Share 2.18
2.31
2.19
2.82
2.90
3.62
4.08
4.45
3.86
4.47
3.38
growth rate 6.0% -5.2% 28.8% 2.8% 24.8% 12.7% 9.1% -13.3% 15.8% -24.4%
Sale Purchase of Stock 68.00
59.00
40.00
27.00
35.00
growth rate -13.2% -32.2% -32.5% 29.6%
FCF 479.00
463.00
599.00
546.00
800.00
867.00
900.00
925.00
1,171.00
2,396.00
2,303.00
growth rate -3.3% 29.4% -8.9% 46.5% 8.4% 3.8% 2.8% 26.6% 104.6% -3.9%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 3,891.60
4,189.50
4,989.00
5,065.00
5,670.00
6,716.00
7,115.00
9,184.00
10,833.00
17,390.00
14,429.00
growth rate 7.7% 19.1% 1.5% 11.9% 18.5% 5.9% 29.1% 18.0% 60.5% -17.0%
Op.Income 618.47
683.09
630.00
865.00
997.00
1,215.00
1,274.00
1,673.00
1,512.00
2,037.00
694.00
growth rate 10.5% -7.8% 37.3% 15.3% 21.9% 4.9% 31.3% -9.6% 34.7% -65.9%
IBT 639.40
697.60
837.00
845.00
1,179.00
1,121.00
1,165.00
1,257.00
1,289.00
1,535.00
313.00
growth rate 9.1% 20.0% 1.0% 39.5% -4.9% 3.9% 7.9% 2.6% 19.1% -79.6%
Net Income 472.00
505.60
630.00
593.00
929.00
757.00
813.00
1,040.00
1,083.00
1,077.00
85.00
growth rate 7.1% 24.6% -5.9% 56.7% -18.5% 7.4% 27.9% 4.1% -0.6% -92.1%
EPS 2.18
2.41
2.77
2.78
4.41
3.50
3.71
4.71
4.07
2.44
0.19
growth rate 10.6% 14.9% 0.4% 58.6% -20.6% 6.0% 27.0% -13.6% -40.1% -92.2%
Gross Profit 2,159.60
2,321.50
2,784.00
2,838.00
3,315.00
4,012.00
4,181.00
5,856.00
6,742.00
10,657.00
8,359.00
growth rate 7.5% 19.9% 1.9% 16.8% 21.0% 4.2% 40.1% 15.1% 58.1% -21.6%
R&D 164.00
188.00
214.00
214.00
60.00
190.00
548.00
544.00
growth rate 14.6% 13.8% 0.0% -72.0% 216.7% 188.4% -0.7%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 470.00
-107.50
-107.50
454.50
454.50
growth rate -100.0% 0.0% 100.0% 0.0%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 2,773.00
2,499.00
2,499.00
2,508.00
2,508.00
growth rate -9.9% 0.0% 0.4% 0.0%
Acct.Payable 1,770.00
1,495.00
1,495.00
1,864.00
1,864.00
growth rate -15.5% 0.0% 24.7% 0.0%
Cur.Assets 10,750.00
13,031.00
13,031.00
13,720.00
13,720.00
growth rate 21.2% 0.0% 5.3% 0.0%
Total Assets 52,583.00
54,054.00
54,054.00
52,318.00
52,318.00
growth rate 2.8% 0.0% -3.2% 0.0%
Cash 4,836.00
7,373.00
7,373.00
8,683.00
8,683.00
growth rate 52.5% 0.0% 17.8% 0.0%
Inventory 2,166.00
2,168.00
2,168.00
1,930.00
1,930.00
growth rate 0.1% 0.0% -11.0% 0.0%
Cur.Liabilities 5,617.00
5,782.00
5,782.00
6,171.00
6,171.00
growth rate 2.9% 0.0% 6.7% 0.0%
Liabilities 17,251.00
19,682.00
19,682.00
19,520.00
19,520.00
growth rate 14.1% 0.0% -0.8% 0.0%
LT Debt 6,864.00
9,384.00
9,384.00
9,324.00
9,324.00
growth rate 36.7% 0.0% -0.6% 0.0%
Equity 34,796.00
33,844.00
33,844.00
32,268.00
32,268.00
growth rate -2.7% 0.0% -4.7% 0.0%
Common Shares 79.00
79.00
79.00
79.00
79.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 232.50
156.00
156.00
169.00
169.00
growth rate -32.9% 0.0% 8.3% 0.0%
Cash Dividends 251.50
251.50
251.50
251.50
growth rate 0.0% 0.0% 0.0%
Cash From OA 905.00
227.00
227.00
1,249.50
1,249.50
growth rate -74.9% 0.0% 450.4% 0.0%
Sale Purchase of Stock
growth rate
FCF 672.50
71.00
71.00
1,080.50
1,080.50
growth rate -89.4% 0.0% 1,421.8% 0.0%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 4,307.00
3,115.00
3,115.00
4,099.50
4,099.50
growth rate -27.7% 0.0% 31.6% 0.0%
Op.Income 470.00
-107.50
-107.50
454.50
454.50
growth rate -100.0% 0.0% 100.0% 0.0%
IBT 278.50
-230.00
-230.00
386.50
386.50
growth rate -100.0% 0.0% 100.0% 0.0%
Net Income 201.00
-206.00
-206.00
248.50
248.50
growth rate -100.0% 0.0% 100.0% 0.0%
EPS
growth rate
Gross Profit 2,628.00
1,738.50
1,738.50
2,441.00
2,441.00
growth rate -33.9% 0.0% 40.4% 0.0%
R&D 139.50
134.00
134.00
138.00
138.00
growth rate -3.9% 0.0% 3.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (42.03)

YOY Growth Grade:

D (41.84)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 785.58 785.37 32.80
EPS / Growth 6.9% 0.19 9.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 31.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.9% 15.9% 15.9%
Future PE 13.76 32.30 32.30
Future EPS 0.37 0.83 0.83
Value Price
MOS %
1.26
-99.2%
6.64
-95.6%
6.64
-95.6%
MOS Price 0.63 3.32 3.32
IRT 59.25 31.76 31.76

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.